Real World Experience With Lorcaserin for Weight Management
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 157
- 试验地点
- 1
- 主要终点
- Duration of Use - in weeks
研究概览
简要总结
This is a retrospective, descriptive study that involves de-identified data consisting of weight changes, pertinent vital signs and laboratory values influenced by body weight, and healthcare utilization of patients prescribed lorcaserin at The Center for Weight Management at the Scripps Clinic in San Diego, CA.
详细描述
All patients who initiated treatment with Lorcaserin during the review period will undergo chart review. The primary endpoint will be weight change in patients on Lorcaserin and average duration of Lorcaserin treatment over time (up to 1 year). Secondary endpoints will include changes in vital signs, liver function, glucose, and lipids. In addition, time on treatment, reasons for discontinuation of medication, and changes in healthcare utilization (to include inpatient and outpatient utilization) will be examined. This is a retrospective, one-arm observational study that will include chart reviews of 157 patients who have been treated in the clinic.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Received at least one prescription for Lorcaserin treatment
- •At least 18 years of age or with guardian/parent able to consent for a minor
排除标准
- •Patient under the age of 18 at time of index date
研究组 & 干预措施
Observational Group - Lorcaserin Treated
The group in this study will be all patients who initiated therapy with Lorcaserin during the review period.
干预措施: Lorcaserin (Drug)
结局指标
主要结局
Duration of Use - in weeks
时间窗: Up to 1 year of medication use
Average duration of treatment with Lorcaserin
Weight change - in pounds
时间窗: Up to 1 year of medication use
Change in weight with Lorcaserin treatment
次要结局
- Change in heart rate(Up to 1 year of medication use)
- Change in blood pressure(Up to 1 year of medication use)
- Change in lipid levels(Up to 1 year of medication use)
- Change in liver enzymes(Up to 1 year of medication use)
- Change in glucose values(Up to 1 year of medication use)
研究者
Athena Philis-Tsimikas
Corporate Vice President
Scripps Whittier Diabetes Institute